Cargando…

FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE(−/−) mice atherosclerosis

Atherosclerosis is a chronic inflammatory vascular disease, and inflammation plays a critical role in its formation and progression. Elevated serum homocysteine (Hcy) is an independent risk factor for atherosclerosis. Previous studies have shown that fatty acid binding protein 4 (FABP4) plays an imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lingbo, Zhang, Huiping, Wang, Yanhua, Yang, Anning, Dong, Xiaoyan, Gu, Lingyu, Liu, Dayue, Ding, Ning, Jiang, Yideng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695379/ https://www.ncbi.nlm.nih.gov/pubmed/34725437 http://dx.doi.org/10.1038/s41374-021-00679-2

Ejemplares similares

miR‐195‐3p alleviates homocysteine‐mediated atherosclerosis by targeting IL‐31 through its epigenetics modifications
por: Xiong, Jiantuan, et al.
Publicado: (2021)

Extracellular-superoxide dismutase DNA methylation promotes oxidative stress in homocysteine-induced atherosclerosis: EC-SOD DNA methylation regulates atherosclerosis in ApoE (–/–) mice
por: Ma, Shengchao, et al.
Publicado: (2022)

TGFB3-AS1 promotes Hcy-induced inflammationof macrophages via inhibiting the maturityof miR-144 and upregulating Rap1a
por: Zhang, Hui, et al.
Publicado: (2021)

Homocysteine induces podocyte apoptosis by regulating miR‐1929‐5p expression through c‐Myc, DNMT1 and EZH2
por: Xie, Lin, et al.
Publicado: (2021)

H3K14 hyperacetylation-mediated c-Myc binding to the miR-30a-5p gene promoter under hypoxia postconditioning protects senescent cardiomyocytes from hypoxia/reoxygenation injury
por: Xu, Lingbo, et al.
Publicado: (2021)

Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe(−/−) Mice
por: Tang, Yang, et al.
Publicado: (2020)

Aberrant MFN2 transcription facilitates homocysteine‐induced VSMCs proliferation via the increased binding of c‐Myc to DNMT1 in atherosclerosis
por: Xu, Long, et al.
Publicado: (2019)

Role of PCSK9 in Homocysteine-Accelerated Lipid Accumulation in Macrophages and Atherosclerosis in ApoE(−/−) Mice
por: Jin, Ping, et al.
Publicado: (2021)

Identification and Validation of Immune-Related Genes Diagnostic for Progression of Atherosclerosis and Diabetes
por: Fu, Yajuan, et al.
Publicado: (2023)

Homocysteine facilitates endoplasmic reticulum stress and apoptosis of hepatocytes by suppressing ERO1α expression via cooperation between DNMT1 and G9a
por: Shen, Jiangyong, et al.
Publicado: (2022)

Interaction between PSMD10 and GRP78 accelerates endoplasmic reticulum stress-mediated hepatic apoptosis induced by homocysteine
por: Xiao, Kun, et al.
Publicado: (2021)

APOE and FABP2 Polymorphisms and History of Myocardial Infarction, Stroke, Diabetes, and Gallbladder Disease
por: Kato, Ikuko, et al.
Publicado: (2011)

Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
por: Yang, Xilan, et al.
Publicado: (2020)

Ischemic Postconditioning Protects against Aged Myocardial Ischemia/Reperfusion Injury by Transcriptional and Epigenetic Regulation of miR-181a-2-3p
por: Li, Guizhong, et al.
Publicado: (2022)

Sorafenib Sensitizes Solid Tumors to Apo2L/TRAIL and Apo2L/TRAIL Receptor Agonist Antibodies by the Jak2-Stat3-Mcl1 Axis
por: Abdulghani, Junaid, et al.
Publicado: (2013)

Homocysteine activates autophagy by inhibition of CFTR expression via interaction between DNA methylation and H3K27me3 in mouse liver
por: Yang, Anning, et al.
Publicado: (2018)

FABP1 and FABP2 as markers of diabetic nephropathy
por: Tsai, I-Ting, et al.
Publicado: (2020)

Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation
por: Xiaoling, Yang, et al.
Publicado: (2016)

Homocysteine accelerates hepatocyte autophagy by upregulating TFEB via DNMT3b-mediated DNA hypomethylation: TFEB accelerates autophagy of hepatocytes with Hcy treatment
por: Yang, Anning, et al.
Publicado: (2023)

FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis
por: TAN, Mürşide, et al.
Publicado: (2019)

Correction: Hyperhomocysteinemia in ApoE-/- Mice Leads to Overexpression of Enhancer of Zeste Homolog 2 via miR-92a Regulation
por: Xiaoling, Yang, et al.
Publicado: (2020)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

Is there any link between homocysteine and atherosclerosis?
por: Duygu, Hamza
Publicado: (2017)

Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris
por: Juczynska, K., et al.
Publicado: (2020)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Candida albicans Induces Foaming and Inflammation in Macrophages through FABP4: Its Implication for Atherosclerosis
por: Haider, Mohammed, et al.
Publicado: (2021)

Heterodimeric JAK-STAT Activation as a Mechanism of Persistence to JAK2 Inhibitor Therapy
por: Koppikar, Priya, et al.
Publicado: (2012)

Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux
por: Dotan, Idit, et al.
Publicado: (2022)

The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass
por: Pan, Sining, et al.
Publicado: (2020)

Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2–STAT3 pathway
por: Chen, Yanhua, et al.
Publicado: (2017)

Elevated retinol binding protein 4 levels are associated with atherosclerosis in diabetic rats via JAK2/STAT3 signaling pathway
por: Zhou, Wan, et al.
Publicado: (2021)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

Computational models of the JAK1/2-STAT1 signaling
por: Gambin, Anna, et al.
Publicado: (2013)

JAK2-STAT5B pathway and osteoblast differentiation
por: Darvin, Pramod, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sr0qhssibbgu00eo2thjqro3t8